Showing results (251-260 of 301) with videos related to

Sort By:
Pageof 31
Advanced Healthcare Materials|July 13, 2024
Hypoxic-Normoxic Crosstalk Activates Pro-Inflammatory Signaling in Human Cardiac Fibroblasts and Myocytes in a Post-Infarct Myocardium on a ChipNatalie N Khalil, Megan L Rexius-Hall, Divya Gupta, et al.
Biomarkers in Cancer|March 22, 2016
Comparative Proteomic Analysis of Advanced Ovarian Cancer Tissue to Identify Potential Biomarkers of Responders and Nonresponders to First-Line Chemotherapy of Carboplatin and PaclitaxelUrmila Sehrawat, Ruchika Pokhriyal, Ashish Kumar Gupta, et al.
Thoracic Cancer|February 4, 2025
Stage IIIA Non-Small Cell Lung Cancer Treatment and Outcomes: A Single Institution Retrospective AnalysisRichard Duan, Michelle Kwan, Avram Kordon, et al.
International Journal of Molecular Sciences|January 11, 2025
Identification of Disease-Relevant, Sex-Based Proteomic Differences in iPSC-Derived Vascular Smooth Muscle CellsNethika R Ariyasinghe, Divya Gupta, Sean Escopete, et al.
Scientific Reports|July 24, 2021
Repeated cross-sectional analysis of hydroxychloroquine deimplementation in the AHA COVID-19 CVD RegistrySteven M Bradley, Sophia Emmons-Bell, R Kannan Mutharasan, et al.
JHLT Open|June 30, 2025
Belatacept-based immunosuppression in heart transplant recipients: A single center experienceWairimu Magua, Maggie Wang, Darlington Pobee, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Identification of Disease-relevant, Sex-based Proteomic Differences in iPSC-derived Vascular Smooth MuscleNethika R Ariyasinghe, Divya Gupta, Sean Escopete, et al.
American Heart Journal|May 18, 2025
Cardiac Allograft Vasculopathy Mediates the Relationship Between Vitamin D Deficiency and Cardiovascular Mortality Following Heart TransplantationMatthew E Gold, Sarah Kulkarni, Adithiya Yadalam, et al.
Cancer Chemotherapy and Pharmacology|July 29, 2021
Pharmacokinetics and safety of niraparib in patients with moderate hepatic impairmentMehmet Akce, Anthony El-Khoueiry, Sarina A Piha-Paul, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 6, 2023
Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutionsThomas J Herzog, Shaun A Wahab, Mansoor R Mirza, et al.
Pageof 31